Aselsan and Metsis Medical have nationalized the production of AED (defibrillator) devices, which are critically important for reviving patients with sudden cardiac arrest using electroshock.
Aselsan announced on its social media account that its domestically produced AED (Automated External Defibrillator) enables the resuscitation of patients with sudden cardiac arrest using electroshock. The AED provides cardiopulmonary resuscitation (CPR) support and measures heart rhythm through ECG analysis, applying a shock to the appropriate patient.
What are the features of the National AED (defibrillator) Device?
• ECG analysis algorithm that identifies heart rhythms requiring shock with high accuracy.
• Ability to deliver shocks (defibrillation) with fully automatic/semi-automatic operating modes.
• Reliable ECG rhythm analysis with motion detection feature.
• Performance that makes a difference with its fast charging feature.
• Cardiac massage and artificial respiration support with visual and auditory guidance.
• Pacemaker detection capability
Note
If you have any photos or video footage to support our news story, please share them with us using the information provided on our contact us page.
